Bioenergetics and Mitochondrial Dysfunction in Aging: Recent Insights for a Therapeutical Approach

Author(s): Antonino Davide Romano, Eulalia Greco, Gianluigi Vendemiale, Gaetano Serviddio

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 18 , 2014

Become EABM
Become Reviewer


The present review points out the role of oxidative stress in aging and the potential therapeutic targets of modern antioxidant therapies.

Mitochondria are essential for several biological processes including energy production by generating ATP through the electron transport chain (ETC) located on the inner mitochondrial membrane. Due to their relevance in cellular physiology, defects in mitochondria are associated with various human diseases.

Moreover, several years of research have demonstrated that mitochondria have a pivotal role in aging. The oxidative stress theory of aging suggests that mitochondria play a key role in aging as they are the main cellular source of reactive oxygen species (ROS), which indiscriminately damage macromolecules leading to an age-dependent decline in biological function.

In this review we will discuss the mitochondrial dysfunction occurring in aging. In particular, we will focus on the novel mitochondria targeted therapies and the new selective molecules and nanocarriers technology as potentially effective in targeting mitochondrial dysfunction and diseases involving oxidative stress and metabolic failure.

Keywords: Aging, mitochondria, mitochondria targeted therapy, oxidative stress.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [2978 - 2992]
Pages: 15
DOI: 10.2174/13816128113196660700
Price: $65

Article Metrics

PDF: 61